A special supplement on contraception and HRT has been published with the December 2019 issue of MIMS.
National statistics data from 2017/18 for England indicate that most of the women who attended sexual and reproductive health services for contraception were using hormonal contraceptives, with 42% using oral contraceptives and 41% using long-acting reversible contraceptives (LARCs).
Approximately a million women in the UK take HRT for menopausal symptoms. In England and Wales £57.2 million is spent every year on HRT and topical oestrogen. In 2013, approximately 85% of HRT used was oral and 15% was transdermal – however, the percentage of women using transdermal HRT was predicted to increase after publication of the NICE menopause guidance in 2015.
The MIMS supplement covers:
- Overview of the menstrual cycle and menopause
- Factors affecting contraceptive choice
- Diagnosis of menopause
- Use of HRT
The supplement is worth 1 CPD credit towards appraisal and revalidation. Claim your printed copy with the December issue of MIMS or download a digital version below.